Showing results (161-170 of 347) with videos related to
Sort By:
Pageof 35
British Journal of Haematology|December 16, 2014
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignanciesFriedhelm R Schuster, Michael Stanglmaier, Wilhelm Woessmann, et al.Haematologica|November 27, 2010
IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approachPolina Stepensky, Michael Weintraub, Asaf Yanir, et al.International Journal of Molecular Sciences|June 27, 2020
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNAAndreas Kloetgen, Sujitha Duggimpudi, Konstantin Schuschel, et al.Journal of Medicinal Chemistry|October 27, 2018
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome InhibitorSanil Bhatia, Viktoria Krieger, Michael Groll, et al.Molecular Oncology|June 22, 2016
A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphomaMaria Joosten, Sebastian Ginzel, Christian Blex, et al.European Journal of Medicinal Chemistry|December 28, 2020
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitorsLeandro A Alves Avelar, Christian Schrenk, Melf Sönnichsen, et al.Cancer Gene Therapy|February 22, 2002
Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapySusanne Frank, Sabine Steffens, Ute Fischer, et al.Haematologica|April 16, 2026
Efficacy of the kinase inhibitor CHZ868 against JAK2 rearrangements in pediatric acute lymphoblastic leukemiaManuel Quadri, Claudia Saitta, Sonia Palamini, et al.Urologic Oncology|February 6, 2014
MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancerMahnaz Nikpour, Modjtaba Emadi-Baygi, Ute Fischer, et al.Cancer Biology & Therapy|March 13, 2014
Limited efficacy of specific HDAC6 inhibition in urothelial cancer cellsLorena Rosik, Günter Niegisch, Ute Fischer, et al.Pageof 35